Literature DB >> 17593207

A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph)angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluation.

G G Van den Eynden1, C G Colpaert, A Couvelard, F Pezzella, L Y Dirix, P B Vermeulen, E A Van Marck, T Hasebe.   

Abstract

A fibrotic focus is a scar-like area in the centre of a carcinoma and can be regarded as a focus of exaggerated reactive tumour stroma formation. Although modern surgical pathology uses different histopathological and molecular markers to assess the aggressiveness and predict the behaviour of malignant tumours, markers reflecting stromal cell behaviour and interactions between epithelial cells and stromal cells are scarce. In this review we summarize all studies investigating the value of a fibrotic focus as a prognostic factor and as a surrogate marker for hypoxia and (lymph)angiogenesis in patients with breast cancer. These data show that a fibrotic focus can be used as a practical, easily assessable and reproducible integrative histological prognostic parameter in breast cancer. We propose a consensus methodology to assess the fibrotic focus in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17593207     DOI: 10.1111/j.1365-2559.2007.02761.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  28 in total

1.  Evaluation of the R2* value in invasive ductal carcinoma with respect to hypoxic-related prognostic factors using iterative decomposition of water and fat with echo asymmetry and least-squares emission (IDEAL).

Authors:  Mari Miyata; Takatoshi Aoki; Shohei Shimajiri; Atsuji Matsuyama; Shunsuke Kinoshita; Masami Fujii; Takefumi Katsuki; Yuzuru Inoue; Yoshika Nagata; Yuko Tashima; Yukunori Korogi
Journal:  Eur Radiol       Date:  2017-04-11       Impact factor: 5.315

2.  Quantitative nuclear histomorphometry predicts oncotype DX risk categories for early stage ER+ breast cancer.

Authors:  Jon Whitney; German Corredor; Andrew Janowczyk; Shridar Ganesan; Scott Doyle; John Tomaszewski; Michael Feldman; Hannah Gilmore; Anant Madabhushi
Journal:  BMC Cancer       Date:  2018-05-30       Impact factor: 4.430

3.  Hypoxic tumor microenvironments reduce collagen I fiber density.

Authors:  Samata M Kakkad; Meiyappan Solaiyappan; Brian O'Rourke; Ioannis Stasinopoulos; Ellen Ackerstaff; Venu Raman; Zaver M Bhujwalla; Kristine Glunde
Journal:  Neoplasia       Date:  2010-08       Impact factor: 5.715

4.  Association between lysyl oxidase and fibrotic focus in relation with inflammation in breast cancer.

Authors:  Young Ju Jeong; Sung Hwan Park; Sung Hee Mun; Sang Gyu Kwak; Sun-Jae Lee; Hoon Kyu Oh
Journal:  Oncol Lett       Date:  2017-12-14       Impact factor: 2.967

Review 5.  Paracrine and endocrine effects of adipose tissue on cancer development and progression.

Authors:  Jiyoung Park; David M Euhus; Philipp E Scherer
Journal:  Endocr Rev       Date:  2011-06-02       Impact factor: 19.871

6.  Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy.

Authors:  Eugenio Maiorano; Meredith M Regan; Giuseppe Viale; Mauro G Mastropasqua; Marco Colleoni; Monica Castiglione-Gertsch; Karen N Price; Richard D Gelber; Aron Goldhirsch; Alan S Coates
Journal:  Breast Cancer Res Treat       Date:  2009-03-12       Impact factor: 4.872

7.  Breast cancer by proxy: can the microenvironment be both the cause and consequence?

Authors:  Lone Rønnov-Jessen; Mina J Bissell
Journal:  Trends Mol Med       Date:  2008-12-16       Impact factor: 11.951

8.  The fibromatosis signature defines a robust stromal response in breast carcinoma.

Authors:  Andrew H Beck; Inigo Espinosa; C Blake Gilks; Matt van de Rijn; Robert B West
Journal:  Lab Invest       Date:  2008-04-14       Impact factor: 5.662

Review 9.  Forcing through Tumor Metastasis: The Interplay between Tissue Rigidity and Epithelial-Mesenchymal Transition.

Authors:  Spencer C Wei; Jing Yang
Journal:  Trends Cell Biol       Date:  2015-10-24       Impact factor: 20.808

Review 10.  In vitro models of tumor vessels and matrix: engineering approaches to investigate transport limitations and drug delivery in cancer.

Authors:  Bo Ri Seo; Peter DelNero; Claudia Fischbach
Journal:  Adv Drug Deliv Rev       Date:  2013-12-02       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.